At BD, I lead FDA 510(k) strategy and submissions, authoring content, coordinating cross-functional teams, and guiding products through FDA review.
I lead FDA interactions and Additional Information responses while assessing sustaining engineering changes to maintain global market access. I also develop EU MDR technical documentation across Class I, IIa, IIb, and Procedure Pack devices.
Previously at Origen Biomedical, I supported clinical evaluations, post-market surveillance, international registrations, EU MDR transition gap assessments, recalls, and FDA 806 reporting across global markets.
My earlier work at Medtronic supported international regulatory submissions, while my CDC research experience included HPLC, mass spectrometry, method validation, laboratory systems implementation, and technical reporting.

